Signe Harring Østoft

Glucose-Lowering Effects and Low Risk of Hypoglycemia in Patients With Maturity-Onset Diabetes of the Young When Treated With a GLP-1 Receptor Agonist: A Double-Blind, Randomized, Crossover Trial

Signe Harring Østoft, Jonatan I. Bagger, Torben Hansen et al. · Diabetes Care · 2014 · 131 citations · Full text

Incretin Effect and Glucagon Responses to Oral and Intravenous Glucose in Patients With Maturity-Onset Diabetes of the Young—Type 2 and Type 3

Signe Harring Østoft, Jonatan I. Bagger, Torben Hansen et al. · Diabetes · 2014 · 51 citations · Full text

The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects

Nicolai A. Rhee, Signe Harring Østoft, Jens J. Holst et al. · European Journal of Endocrinology · 2014 · 30 citations

Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young

Signe Harring Østoft, Jonatan I. Bagger, Torben Hansen et al. · European Journal of Endocrinology · 2015 · 13 citations

Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.

Signe Harring Østoft · PubMed · 2015 · 10 citations